NO975002L - Azoforbindelse til för döden diagnose av Alzheimers sykdom og in vivo billeddannelse og forhindring av amyloide deponeringer - Google Patents

Azoforbindelse til för döden diagnose av Alzheimers sykdom og in vivo billeddannelse og forhindring av amyloide deponeringer

Info

Publication number
NO975002L
NO975002L NO975002A NO975002A NO975002L NO 975002 L NO975002 L NO 975002L NO 975002 A NO975002 A NO 975002A NO 975002 A NO975002 A NO 975002A NO 975002 L NO975002 L NO 975002L
Authority
NO
Norway
Prior art keywords
amyloid deposits
derivatives
alzheimer
methods
disease
Prior art date
Application number
NO975002A
Other languages
English (en)
Norwegian (no)
Other versions
NO975002D0 (no
Inventor
William E Klunk
Jay W Pettergrew
Jr Chester A Mathis
Original Assignee
Univ Pittsburgh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Pittsburgh filed Critical Univ Pittsburgh
Publication of NO975002D0 publication Critical patent/NO975002D0/no
Publication of NO975002L publication Critical patent/NO975002L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C245/00—Compounds containing chains of at least two nitrogen atoms with at least one nitrogen-to-nitrogen multiple bond
    • C07C245/02—Azo compounds, i.e. compounds having the free valencies of —N=N— groups attached to different atoms, e.g. diazohydroxides
    • C07C245/06—Azo compounds, i.e. compounds having the free valencies of —N=N— groups attached to different atoms, e.g. diazohydroxides with nitrogen atoms of azo groups bound to carbon atoms of six-membered aromatic rings
    • C07C245/08—Azo compounds, i.e. compounds having the free valencies of —N=N— groups attached to different atoms, e.g. diazohydroxides with nitrogen atoms of azo groups bound to carbon atoms of six-membered aromatic rings with the two nitrogen atoms of azo groups bound to carbon atoms of six-membered aromatic rings, e.g. azobenzene
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C245/00—Compounds containing chains of at least two nitrogen atoms with at least one nitrogen-to-nitrogen multiple bond
    • C07C245/02—Azo compounds, i.e. compounds having the free valencies of —N=N— groups attached to different atoms, e.g. diazohydroxides
    • C07C245/06—Azo compounds, i.e. compounds having the free valencies of —N=N— groups attached to different atoms, e.g. diazohydroxides with nitrogen atoms of azo groups bound to carbon atoms of six-membered aromatic rings
    • C07C245/10—Azo compounds, i.e. compounds having the free valencies of —N=N— groups attached to different atoms, e.g. diazohydroxides with nitrogen atoms of azo groups bound to carbon atoms of six-membered aromatic rings with nitrogen atoms of azo groups bound to carbon atoms of six-membered aromatic rings being part of condensed ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/24—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/06—Ring systems of three rings
    • C07D221/14—Aza-phenalenes, e.g. 1,8-naphthalimide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/28—Cinnolines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30—Phthalazines
    • C07D237/32—Phthalazines with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/20—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/02—1,2-Oxazines; Hydrogenated 1,2-oxazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/24—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in positions 2 and 4
    • C07D265/26—Two oxygen atoms, e.g. isatoic anhydride
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/10—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/22—Tin compounds
    • C07F7/2208—Compounds having tin linked only to carbon, hydrogen and/or halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/06—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
    • C07C2603/10—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
    • C07C2603/12—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
    • C07C2603/18—Fluorenes; Hydrogenated fluorenes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/22—Ortho- or ortho- and peri-condensed systems containing three rings containing only six-membered rings
    • C07C2603/26—Phenanthrenes; Hydrogenated phenanthrenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
NO975002A 1995-05-01 1997-10-30 Azoforbindelse til för döden diagnose av Alzheimers sykdom og in vivo billeddannelse og forhindring av amyloide deponeringer NO975002L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US43201995A 1995-05-01 1995-05-01
PCT/US1996/005918 WO1996034853A1 (fr) 1995-05-01 1996-05-01 Composes azo destines au diagnostic avant la mort de la maladie d'alzheimer, a l'imagerie in vivo ainsi qu'a la prevention du depot de substance amyloide

Publications (2)

Publication Number Publication Date
NO975002D0 NO975002D0 (no) 1997-10-30
NO975002L true NO975002L (no) 1998-01-02

Family

ID=23714410

Family Applications (1)

Application Number Title Priority Date Filing Date
NO975002A NO975002L (no) 1995-05-01 1997-10-30 Azoforbindelse til för döden diagnose av Alzheimers sykdom og in vivo billeddannelse og forhindring av amyloide deponeringer

Country Status (10)

Country Link
EP (2) EP0823894A1 (fr)
JP (1) JPH11505526A (fr)
KR (1) KR19990008328A (fr)
AU (1) AU712552B2 (fr)
CA (1) CA2219880A1 (fr)
HU (1) HUP9900426A3 (fr)
MX (1) MX9708425A (fr)
NO (1) NO975002L (fr)
NZ (1) NZ307369A (fr)
WO (1) WO1996034853A1 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6168776B1 (en) * 1994-07-19 2001-01-02 University Of Pittsburgh Alkyl, alkenyl and alkynyl Chrysamine G derivatives for the antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition
US6417178B1 (en) 1994-07-19 2002-07-09 University Of Pittsburgh Amyloid binding nitrogen-linked compounds for the antemortem diagnosis of alzheimer's disease, in vivo imaging and prevention of amyloid deposits
US6054114A (en) * 1996-05-08 2000-04-25 Massachusetts Institute Of Technology Organometallic ligands for the localization and quantification of amyloid in vivo and in vitro
WO1998048846A1 (fr) * 1997-04-29 1998-11-05 Nycomed Imaging As Agents de contraste utilises dans des techniques d'imagerie basees sur la lumiere
ZA989365B (en) * 1997-10-15 1999-04-15 Boehringer Mannheim Pharm Corp Preparation for treating alzheimer's disease
DK1334091T3 (da) 2000-08-24 2012-10-15 Univ Pittsburgh Thioflavinderivater og deres anvendelse til diagnose og terapi af Alzheimer's sygdom
US6589504B1 (en) 2000-09-22 2003-07-08 Pharmacia & Upjohn Company Compounds and methods for diagnosing and treating amyloid-related conditions
WO2002028441A2 (fr) * 2000-10-04 2002-04-11 California Institute Of Technology Agents d'imagerie par resonance magnetique pour la detection et l'etiquetage in vivo de depots amyloides
US6479528B1 (en) * 2001-07-31 2002-11-12 Neuronautics, Inc. Methods for inhibiting or reversing tau filament formation polymerization
JP2006510722A (ja) * 2002-01-29 2006-03-30 プロテミックス コーポレイション リミティド 細胞障害性タンパク質コンフォーマーの抑制
GB0307855D0 (en) 2003-04-04 2003-05-14 Novartis Ag Organic compounds
US20090087376A1 (en) * 2004-07-15 2009-04-02 The General Hospital Corporation Heterocyclic Dye Compounds For In Vivo Imaging And Diagnosis Of Alzheimer's Disease
JP2007084526A (ja) * 2004-11-26 2007-04-05 Nagasaki Univ アミロイド関連疾患診断用組成物
WO2006116736A2 (fr) * 2005-04-27 2006-11-02 Siemens Medical Solutions Usa, Inc. Procede chimique in situ de criblage de sondes d'imagerie moleculaire de haute affinite
US7910579B2 (en) 2006-12-25 2011-03-22 Tohoku University Benzoxazole derivatives
CN102762229B9 (zh) * 2009-12-23 2020-12-01 皮拉马影像股份公司 适用于用疏水pet试剂pet成像的配方

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58174459A (ja) * 1982-04-06 1983-10-13 Canon Inc 記録液及びこれを用いたインクジェット記録方法
JPS59100450A (ja) * 1982-11-30 1984-06-09 Mitsubishi Paper Mills Ltd 電子写真用感光体
JPS60205454A (ja) * 1984-03-29 1985-10-17 Mitsubishi Paper Mills Ltd 電子写真感光体
US5039511A (en) * 1987-04-08 1991-08-13 Salutar, Inc. Amyloidosis and alzheimer's disease diagnostic assay and reagents therefor
JPS63290858A (ja) * 1987-04-08 1988-11-28 サルター・インコーポレーテツド アミロイド症及びアルツハイマー病の診断分析法及びそのための試薬
US4933156A (en) * 1987-04-08 1990-06-12 Salutar, Inc. Amyloidosis and Alzheimer's disease diagnostic assay and reagents therefor
JPS63301045A (ja) * 1987-05-30 1988-12-08 Toshiba Corp 正帯電電子写真感光体
JPS63301047A (ja) * 1987-05-30 1988-12-08 Toshiba Corp 積層型正帯電電子写真感光体
US5276059A (en) * 1992-07-10 1994-01-04 The United States Of America As Represented By The Department Of Health And Human Services Inhibition of diseases associated with amyloid formation

Also Published As

Publication number Publication date
NZ307369A (en) 1999-11-29
EP0823894A1 (fr) 1998-02-18
KR19990008328A (ko) 1999-01-25
EP1110945A2 (fr) 2001-06-27
WO1996034853A1 (fr) 1996-11-07
NO975002D0 (no) 1997-10-30
AU5669296A (en) 1996-11-21
EP1110945A3 (fr) 2003-05-07
MX9708425A (es) 1998-08-30
JPH11505526A (ja) 1999-05-21
HUP9900426A3 (en) 2001-12-28
AU712552B2 (en) 1999-11-11
CA2219880A1 (fr) 1996-11-07
HUP9900426A2 (hu) 1999-05-28

Similar Documents

Publication Publication Date Title
NO995088L (no) Alkyl, alkenyl og alkynyl krysamin G derivater for foer-doeden- diagnose av Alzheimers sykdom og in vivo avbildning og hindring av amyloidavsetning
NO20002380L (no) Forbindelser for før-døden diagnose av Alzheimers sykdom og in vivo billeddannelse, samt forhindring av amyloid deponering
NZ307369A (en) Azocompounds for the antemortem diagnosis of alzheimer's disease and in vivo imaging and prevention of amyloid deposition
Li et al. A theranostic agent for in vivo near-infrared imaging of β-amyloid species and inhibition of β-amyloid aggregation
JP5557449B2 (ja) アミロイド生成性タンパク質の造影剤としての同位体標識ベンゾフラン化合物
US8168800B2 (en) Aβ-binding small molecules
WO2008005534A3 (fr) Formulations à dissolution orale de mémantine
DE19649971A1 (de) Optische Diagnostika zur Diagnostik neurodegenerativer Krankheiten mittels Nahinfrarot-Strahlung (NIR-Strahlung)
WO2002038794A3 (fr) Cibles diagnostiques et therapeutiques pour maladies cardio-vasculaires
NO983287L (no) Perfluorholdige metallkomplekser, fremgangsmåte for fremstilling av slike og deres anvendelse ved NMR-diagnostikk
CN112351974A (zh) 直接抑制asm活性的新型化合物2-氨基-2-（1,2,3-三唑-4-基）-1,3-丙二醇衍生物及其应用
IL91005A (en) Salts of ranitidine with bismuth carboxylic acid complexes, their preparation and pharmaceutical compositions containing them
WO2011014648A2 (fr) Procédés et système destinés à détecter l'amyloïde-β soluble
WO2004064869A3 (fr) Agent de chelation metallique, a liaison amyloide
ES2798254T3 (es) Proceso para la obtención de pteroestilbeno purificado y métodos de uso del mismo
NO20080498L (no) Fluorsubstituerte 2-okso-azepanderivater
UA61875C2 (en) A medicament for use in the treatment of amyloidosis, an anthracycline and a pharmaceutical composition
RU2003138027A (ru) Способ диагностики поструальных нарушений у пациентов с органической патологией головного мозга
Güngör et al. Synthesis, biological evaluation and docking study of mono‐and Di‐sulfonamide derivatives as antioxidant agents and acetylcholinesterase inhibitors
AU2004263025A1 (en) Macrophage activation inhibitor
Furuta et al. Synthesis of neuroprotective cyclopentenone prostaglandin analogs: Suppression of manganese-induced apoptosis of PC12 cells
Komsta et al. Tissue distribution metabolism and excretion of 2, 2′, 4, 4′, 5-pentachlorodiphenyl ether in the rat
Ieda et al. Investigation of the substituent effect of indocyanine green derivatives for lymph imaging
Camarda et al. Isolated, subtle neurological abnormalities in mild cognitive impairment types
Dalmaz et al. The pattern of urinary catecholamines and their metabolites in Duchenne myopathy, in relation to disease evolution

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application